News | January 02, 2024
Inspira Technologies closes on $3.88 million RDO
H.C. Wainwright & Co. acted as the exclusive placement agent for the offering
H.C. Wainwright & Co. acted as the exclusive placement agent for the offering
The survey data presented in “The State of the Biopharmaceutical Industry 2024” report reveals that N=21 (18%) of industry professionals were convinced that CGT will dominate as the most important trend in pharma next year
Ecolab’s continued leadership position on renowned sustainability indices demonstrates the company’s record of advancing sustainable growth
MedTech Mitra is a platform that will help the young talents of the country by holding their hands and giving them final shape to their research, knowledge and logic
Five batches across four programs of Biocon Academy participated in the graduation ceremony
Dr. Reddy's has been awarded 'Gold Medal' status by EcoVadis
This development is a strategic part of the company's commitment to bolstering its position in the advanced pharmaceutical intermediates segment
Express Scripts to add Zepbound to National Preferred Formulary
Dr. Reddy's will make a US$ 7.5 million upfront payment to Coya
Carmot Therapeutics’s R&D portfolio of clinical stage incretins has great potential to treat obesity, diabetes and potentially other diseases
Subscribe To Our Newsletter & Stay Updated
